Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 5 | 2016 | 747 | 0.550 |
Why?
|
| Exosomes | 2 | 2016 | 124 | 0.530 |
Why?
|
| Arteries | 1 | 2017 | 81 | 0.500 |
Why?
|
| Brain | 2 | 2021 | 1452 | 0.400 |
Why?
|
| Macrophages | 1 | 2015 | 515 | 0.360 |
Why?
|
| Aging | 1 | 2017 | 764 | 0.360 |
Why?
|
| Intracranial Hemorrhages | 2 | 2021 | 30 | 0.340 |
Why?
|
| MicroRNAs | 1 | 2015 | 501 | 0.320 |
Why?
|
| HIV Infections | 4 | 2016 | 2535 | 0.290 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2013 | 53 | 0.270 |
Why?
|
| Phagocytosis | 2 | 2021 | 83 | 0.210 |
Why?
|
| Brain Infarction | 1 | 2021 | 22 | 0.180 |
Why?
|
| Microglia | 2 | 2021 | 204 | 0.180 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 44 | 0.180 |
Why?
|
| Hematoma | 1 | 2020 | 15 | 0.170 |
Why?
|
| Brain Stem Infarctions | 1 | 2020 | 1 | 0.170 |
Why?
|
| Cerebellar Diseases | 1 | 2020 | 3 | 0.170 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 2803 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 115 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 81 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 86 | 0.150 |
Why?
|
| Autopsy | 1 | 2017 | 46 | 0.130 |
Why?
|
| Neurons | 2 | 2021 | 1246 | 0.130 |
Why?
|
| Aged | 6 | 2021 | 7982 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 310 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 225 | 0.100 |
Why?
|
| Humans | 11 | 2022 | 42163 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 534 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2013 | 301 | 0.100 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 51 | 0.090 |
Why?
|
| Middle Aged | 5 | 2021 | 11819 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1679 | 0.090 |
Why?
|
| Transport Vesicles | 1 | 2010 | 22 | 0.080 |
Why?
|
| Male | 6 | 2021 | 22779 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 246 | 0.080 |
Why?
|
| Female | 6 | 2022 | 24018 | 0.080 |
Why?
|
| Young Adult | 2 | 2017 | 4936 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2012 | 875 | 0.070 |
Why?
|
| Adult | 4 | 2021 | 13458 | 0.070 |
Why?
|
| Molecular Epidemiology | 1 | 2003 | 58 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2003 | 67 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 38 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 1188 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 1559 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 30 | 0.050 |
Why?
|
| Bacteremia | 1 | 2021 | 37 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 71 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 38 | 0.040 |
Why?
|
| Mutant Proteins | 2 | 2012 | 52 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2020 | 23 | 0.040 |
Why?
|
| Olivary Nucleus | 1 | 2020 | 2 | 0.040 |
Why?
|
| Cerebellar Nuclei | 1 | 2020 | 5 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 21 | 0.040 |
Why?
|
| Survival Rate | 1 | 2021 | 353 | 0.040 |
Why?
|
| Transfection | 2 | 2013 | 526 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2021 | 124 | 0.040 |
Why?
|
| Medulla Oblongata | 1 | 2020 | 40 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2020 | 52 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 201 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 649 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 317 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 357 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 378 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 640 | 0.040 |
Why?
|
| Inflammation | 1 | 2021 | 729 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1420 | 0.030 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 14 | 0.030 |
Why?
|
| Virion | 1 | 2016 | 73 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2016 | 122 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2598 | 0.030 |
Why?
|
| China | 1 | 2015 | 233 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 456 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 94 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 52 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 188 | 0.020 |
Why?
|
| Static Electricity | 1 | 2012 | 85 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 661 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 185 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 491 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1617 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 273 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 150 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 226 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 427 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 1597 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 183 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 670 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 26 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1076 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 207 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 295 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 293 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1058 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1416 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 1169 | 0.010 |
Why?
|
| United States | 1 | 2015 | 5072 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 5950 | 0.010 |
Why?
|
| Barbados | 1 | 2003 | 3 | 0.010 |
Why?
|
| HIV Protease | 1 | 2003 | 22 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2003 | 35 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2003 | 52 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 508 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 429 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 740 | 0.010 |
Why?
|